NCT03090958: AQ

AllyQuest: Engaging HIV+ YMSM in Care Through Social Networking and Gamification

Completed NA Results posted Last updated 11 July 2018

What this trial tests

NA trial testing AllyQuest in Hiv in 20 participants. Completed in 3 January 2017.

Timeline

1 August 2015

Primary endpoint
3 January 2017

3 January 2017

Quick facts

Lead sponsor	University of North Carolina, Chapel Hill
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	20
Start date	1 August 2015
Primary completion	3 January 2017
Estimated completion	3 January 2017

Drugs / interventions tested

• AllyQuest

Conditions studied

• Hiv — all drugs for Hiv →
• HIV/AIDS — all drugs for HIV/AIDS →

Sponsor

University of North Carolina, Chapel Hill

Who can join

Adults 16 to 24, male only, with Hiv or HIV/AIDS. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants That Were Enrolled of Those Screened Primary · 4 weeks

Feasibility of AllyQuest will be based on recruitment success as measured by the total number of individuals who are screened vs. the total number of individuals who are recruited and subsequently enrolled.

Group	Value	95% CI
AllyQuest Pilot	20

Number of Participants That Missed Follow up Interviews Primary · 4 weeks

Feasibility of AllyQuest will be based retention as measured by the number of missed follow up interviews. Follow up attempts will be documented.

Group	Value	95% CI
AllyQuest Pilot	17

Average Number of Days Participants Logged in. Primary · 4 weeks

Feasibility of AllyQuest will be based on usage as measured by the average number days participants access the app.

Group	Value	95% CI
AllyQuest Pilot	21.2	± 14.1

Number of Individuals Who Enroll But do Not Participate Primary · 4 weeks

Feasibility of AllyQuest will be based on the number of individuals who enroll and do not participate.

Group	Value	95% CI
AllyQuest Pilot	3

Average Total Time in Minutes Participants Spent Using App. Primary · 4 weeks

Feasibility of AllyQuest will be based on usage as measured by the average time spent using app.

Group	Value	95% CI
AllyQuest Pilot	158.4	± 114.1

Average Number of App Actions by Participants Primary · 4 weeks

Feasibility of AllyQuest will be based on usage as measured by the average number of activities completed (daily quests), articles read, and social posts made.

Articles read

Group	Value	95% CI
AllyQuest Pilot	8.8	± 7.3

Social wall posts

Group	Value	95% CI
AllyQuest Pilot	12.9	± 12.5

Daily Quests

Group	Value	95% CI
AllyQuest Pilot	15.8	± 13.5

Average Days Participants Logged Medications. Primary · 4 weeks

Feasibility of AllyQuest will be based on usage as measured by the average number of days participants logged their medications in the app.

Group	Value	95% CI
AllyQuest Pilot	19.4	± 13.2

System Usability Scale Scores Secondary · 4 weeks

Acceptability of AllyQuest will be measured by the System Usability Scale (SUS). An 11-item, 7-point Likert scale of subjective assessments of usability (1=strongly agree; 7=strongly disagree). The SUS is technology independent and provides a global measure of system satisfaction and sub-scales of usability and learnability.

Would use this app frequently

Group	Value	95% CI
AllyQuest Pilot	4.41	± 1.18

App was easy to use

Group	Value	95% CI
AllyQuest Pilot	4.76	± 0.56

Felt very confident using the app

Group	Value	95% CI
AllyQuest Pilot	4.47	± 1.01

App is accurate

Group	Value	95% CI
AllyQuest Pilot	4.53	± 1.01

App is dependable

Group	Value	95% CI
AllyQuest Pilot	4.53	± 0.62

Interaction with app is consistent

Group	Value	95% CI
AllyQuest Pilot	4.18	± 0.95

Found app unnecessarily complex

Group	Value	95% CI
AllyQuest Pilot	1.65	± 0.86

Would need technical assistance to use app

Group	Value	95% CI
AllyQuest Pilot	1.71	± 1.16

Client Satisfaction Questionnaire Score Secondary · 4 weeks

Acceptability of AllyQuest will be assessed using the Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 was used to assess global intervention satisfaction. The CSQ-8 has eight items (quality of app, kind of service received from app, app met needs, recommend app to a friend, amount of help received from app, effectiveness of app for dealing with health problem, overall satisfaction, and willingness to use the app again). These domains are assessed on a 4-point response scale with individually specified anchors. Participant responses are scored from 1 to 4, and thus the possible total score

Group	Value	95% CI
AllyQuest Pilot	27.8	± 5.9

Sponsor's own description

AllyQuest is a novel, high impact secondary prevention intervention delivered via mobile phones to improve linkage and engagement in care among newly diagnosed HIV+ young men who have sex with men (YMSM). The features of the intervention aim to target previously identified barriers to care among newly diagnosed youth, namely, low HIV health literacy, lack of social support, and internalized stigma related to their diagnosis. AllyQuest will be an interactive mobile phone intervention for HIV+ YMSM that utilizes social networking, game-based mechanics and a story-based framework to guide behavior change. Grounded in Social Cognitive Theory, narrative communication and the principles of persuasive technology, the intervention is designed to capitalize on social involvement as a means through which HIV+ YMSM can receive information and social support, experience social norms and reflective appraisals, and feel a sense of connectedness to peers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.